News
20hon MSN
New research has identified specific blood-based biomarkers that can predict the failure of prostate cancer treatment in both ...
Under the terms of the agreement, Renovaro and Amsterdam UMC will work together to refine and improve predictive performance, ...
19h
Amazon S3 on MSNAspirin May Hold the Key to Stopping Cancer Spread!In a groundbreaking discovery, scientists from the University of Cambridge have found that aspirin could play a key role in ...
14h
News Medical on MSNBlood-based biomarkers predict therapy failure in prostate cancer patientsNew research has identified specific blood-based biomarkers that can predict the failure of prostate cancer treatment in both hormone-sensitive and castration-resistant patients.
Treatment with the Avmapki Fakzynja Co-pack received accelerated FDA approval for previously treated low-grade serous ovarian ...
The first patient was dosed in the SKYBRIDGE study assessing peluntamig with Tecentriq for advanced small cell lung cancer ...
4d
MedPage Today on MSNFDA OKs Combination for Low-Grade Serous Ovarian CancerThe FDA granted accelerated approval to the combination of avutometinib and defactinib (Avmapki Fakzynja Co-pack) for the ...
SIOUX CITY (KTIV) - LifeServe Blood Center will be in Woodbury County several times in June for blood drives. Four events ...
The FDA has granted accelerated approval to Avmapki (avutometinib) plus Fakzynja (defactinib) for the treatment of KRAS-mutated, recurrent low-grade serous ovarian cancer.
The Food and Drug Administration (FDA) has granted accelerated approval to Avmapki ™ (avutometinib) plus Fakzynja ™ (defactinib) for the treatment of adult patients with KRAS -mutated recurrent ...
A 12-year-old British girl has recovered fully from leukemia—blood cancer—after it returned four times ever since she was ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results